Amylin Pharmaceutics and Eli Lilly & Co., in a partnership with Altea Therapeutics, are developing a patch to deliver a daily dose of BYETTA (exenatide). Recently, early safety testing of the patch was completed.
Altea's is a privately held, development stage company. It makes the PassPort System, which is designed to deliver water-soluble drugs through the skin. The full Associated Press news release ishere.Check out Altea's PassPort Patch delivery system here.
|
The full Associated Press news release ishere.
Check out Altea's PassPort Patch delivery system here.